Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Wow! Man Paralyzed in Diving Mishap Has Medical Miracle a Year after AI-Powered Brain Implant

US Cities Hit PAUSE on Water Fluoridation in the Wake of Historic Ruling

Alberta Premier Confirms Forthcoming Bill to Ban Gender Reassignment Surgery for Children

Virginia Teacher Fired over Pronoun Use Wins Settlement

'Banned Books Week' Reveals the Depravity of the American Library Association and Its Allies

Toyota/Lexus Reverses Course, Stops Woke Practices after Being Called Out

Fire Fighters Union Refuses to Endorse Harris: 'Best Way to Preserve and Strengthen Our Union'

Dockworkers Suspend Strike Until January

Death Toll Climbs to At Least 200 in Southeast, Hundreds Still Missing or Trapped amid Helene Devastation

Miracles and Mysteries: For KING + COUNTRY Singer Joel Smallbone's Powerful Mission to Inspire after 'Unsung Hero'

NC Flooding: This Family's Account of Hope in the Midst of Tragedy Will Build Your Faith

22 States Ask Court to Block Biden-Harris Rule Allowing 'Transgender' Males in Girls' Sports, Bathrooms

'A Game Changer': Another Women's Volleyball Team Refuses to Play against Male Opponent; 'Don't Be Surprised If More Schools Follow Suit'

No Autopsy for 'Wrongly Accused' Pro-Life January 6 Protester Who Died Suddenly in Federal Custody

RNC Announces Even More Election Integrity Wins Ahead of November Election

ICE: Illegal Alien Sanctuaries Shielding 'Dangerous Criminals' Victimizing Their Communities

Shameful: Biden-Kamala Regime Used $1 BILLION in FEMA Funds for Illegal Aliens; FEMA Now Lacks Money for Disaster Response!

Netflix Suffers Record Cancellations after Co-Founder Donates $7 Million to Kamala Harris

'It's Heartwarming': In Hurricane Helene Aftermath Neighbors Serve One Another Despite Loss

Georgia Judge 'Denies Humanity of Unborn Children' by Striking Down 6-Week Protection, Expert Says